Product fact sheet

Hooga PRO750 Technical Profile

Name: Hooga PRO750
Brand: Hooga

Hooga PRO750 specifications list 150 dual-chip LEDs, 660/850 nm output, a 60° beam angle, 750 W nominal lamp power and 272 W electrical consumption.

Red-light therapy guideReturn to the therapy guide and compare device specifications in context. Compare in context → Red-light panel comparisonOpen the comparison surface for this product family; missing comparable data is shown rather than guessed. Compare products →

Desk researchedFacts checked 2026-08-11

A two-wavelength PRO-series panel with 150 dual-chip LEDs and a current primary manual that separates its 750 W lamp-power label from 272 W listed electrical consumption.

Fit signals

mid-size two-wavelength comparisons, buyers who want nominal lamp power separated from electrical input

Potential constraints

buyers requiring independent optical measurements, anyone comparing lamp-power labels directly with wall power

Key tradeoff: The current manual is specific about hardware, but the irradiance charts remain manufacturer-generated.

This is a factual fit-and-tradeoff summary, not a product recommendation. Formula, device and brand claims remain manufacturer claims unless the cited source is explicitly regulatory or independent testing.

Technical record

Hooga’s current PRO-series manual lists the PRO750 at 20.4 × 8.6 × 3.1 inches, with 150 × 5 W dual-chip LEDs, 660 nm and 850 nm wavelengths and a 60° beam angle. The same table lists 750 W lamp power and 272 W power consumption—two deliberately separate fields.

That distinction matters. A nominal aggregate LED/lamp rating is not the same quantity as electrical wall consumption or optical radiant output.

Evidence boundary

The manual also contains manufacturer irradiance and coverage charts. Those charts are not independent laboratory verification, and no compatible third-party common-protocol optical result is currently available for the PRO750.

That makes the 272 W electrical-consumption figure more directly comparable with other electrical inputs than the 750 W nominal lamp-power label. Neither number is a substitute for measured optical irradiance.

Regulatory language

Hooga’s separate quality documentation distinguishes facility, listing and certification language from finished-panel clearance. That scope should remain explicit rather than being compressed into a generic certification badge.

Technical specifications

Published specs and what they mean

Physical

Dimensions: 20.4 × 8.6 × 3.1 in

Optical

Wavelengths: 660 / 850 nm
LED quantity: 150 × 5 W dual-chip LEDs
Lamp power rating: 750 W
Beam angle: 60°

Electrical

Power consumption: 272 W
Power input: AC 85–265 V

Environment

Operating temperature: 32–90°F

What the current record does not establish

No independent common-protocol irradiance measurement is normalized.
Manufacturer irradiance/coverage charts are not treated as laboratory verification.
No Homeapotherapy hands-on measurements exist.

A missing field is not evidence that the device lacks the feature or performs poorly. It means we do not currently have a sufficiently comparable, sourced value in the normalized record.

Source labels preserve provenance. Manufacturer specifications, ingredient lists and performance claims are not treated as independent clinical evidence; regulatory records and independent measurements are identified separately when available.

Dose and irradiance context

What the output number means over time

Fluence is a calculation, not a treatment recommendation. For continuous output, fluence in J/cm² equals irradiance in mW/cm² × seconds ÷ 1000. The calculation only remains meaningful at the measurement conditions used for the irradiance value.

No comparable independent average irradiance is normalized

This device may have a manufacturer-published irradiance claim, but Homeapotherapy does not calculate time-to-fluence from that number unless the current record contains a sufficiently defined independent area-average measurement. This avoids presenting unlike measurement methods as interchangeable.

What this calculation still cannot tell you

whether this is an effective dose for any condition;
how irradiance changes at a different distance or across curved anatomy;
how much energy reaches tissue below the surface;
whether a study used the same wavelength distribution, spot size, pulse mode or treatment schedule;
whether peak irradiance would produce the same area exposure as the average value shown here.

Read Red Light Irradiance, Fluence and Dose Explained before trying to compare this output with a clinical paper or another panel.

Clinical evidence context

Where these wavelengths overlap with human research

Published device wavelengths: 660 / 850 nm.

This is a hardware-to-literature cross-reference, not a claim that this product treats any condition. A matching nominal wavelength does not reproduce a study's irradiance, dose, distance, treatment area, emitter geometry, schedule or patient population.

Research areas worth checking

Pattern hair loss — human studies commonly use visible-red wavelengths, especially around the mid-600 nm range.
Acne and inflammatory skin — red-light protocols exist, but acne studies may also use blue light and should not be generalized from panel specs.
Skin rejuvenation and photoaging — visible-red and red/NIR LED protocols have been studied with varied devices and endpoints.
Knee osteoarthritis — near-infrared wavelengths appear in the clinical literature, but wavelength alone does not establish an equivalent treatment protocol.
Muscle recovery and musculoskeletal pain — research spans red and near-infrared bands with substantial protocol variation.
Transcranial PBM and cognition — some research uses near-infrared wavelengths, but a body panel is not automatically equivalent to a head-targeted transcranial device.
See the full wavelength-by-condition evidence chart for evidence strength, treatment geometry and major caveats.

Do not infer from wavelength overlap

that this device is clinically proven for the linked condition;
that more wavelengths are better;
that the highest published irradiance is the best dose;
that an open wound should be treated with a consumer device without appropriate wound assessment.

For wounds specifically, start with the wound-care safety decision guide before interpreting any device specification.

Safety first

What should make you slow down?

Follow the current PRO-series manual and keep manufacturer performance claims separate from clinical evidence.

The manual includes device safety and eye-exposure warnings.
Electrical and nominal lamp-power figures describe different quantities and should not be compared as though they were the same measurement.

Where to buy

Current tracked merchants

Commerce note: merchant economics never enter our editorial score. Affiliate links are identified as (paid link) and use sponsored-link markup.

No merchant destination is currently tracked for this product.

Source trail

Primary documents and supporting evidence

Hooga PRO Series User ManualHooga · Manufacturer manual · PDF · retrieved 2026-08-11
Hooga Quality & Certifications: What We Can VerifyHooga · Manufacturer · retrieved 2026-08-10
Photobiomodulation (PBM) Devices - Premarket Notification [510(k)] SubmissionsU.S. Food and Drug Administration · Regulatory · retrieved 2026-08-10

Comparable products